Financial statements Efekt-Pharm
Balance sheet data of EFEKT-PHARM
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 1 047 252,70 | 977 995,90 | 947 380,74 | 1 056 270,23 | 1 054 663,79 |
| A. Fixed assets | 154 487,57 | 90 434,28 | 60 729,54 | 192 965,80 | 180 957,92 |
| B. Current assets | 892 765,13 | 887 561,62 | 886 651,20 | 863 304,43 | 873 705,87 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 1 047 252,70 | 977 995,90 | 947 380,74 | 1 056 270,23 | 1 054 663,79 |
| A. Equity | 286 183,91 | 513 129,12 | 560 218,66 | 676 125,29 | 735 665,55 |
| B. Liabilities and provisions for liabilities | 761 068,79 | 464 866,78 | 387 162,08 | 380 144,94 | 318 998,24 |
| I. Long-term liabilities | 0,00 | 19 444,46 | 3 312,50 | 0,00 | 0,00 |
| II. Short-term liabilities | 668 288,62 | 442 129,55 | 378 696,42 | 372 493,13 | 312 483,99 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.